Antibody Therapeutics and Blood Antibody Therapeutics market

Antibody Therapeutics and Blood Antibody Therapeutics Market - Global Outlook and Forecast 2022-2028

  • 21 January 2022
  • Life Sciences
  • 71 Pages
  • Report code : PMR-6790320

  • 4.7 (158)

Antibody Therapeutics and Blood Antibody Therapeutics Market

Download FREE Report Sample

  Download Free sample

Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.

Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.

Antibody Therapeutics and Blood Antibody Therapeutics Market contains market size and forecasts of Antibody Therapeutics and Blood Antibody Therapeutics in Global, including the following market information:

Global Antibody Therapeutics and Blood Antibody Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antibody Therapeutics and Blood Antibody Therapeutics market was valued at 196950 million in 2021 and is projected to reach US$ 371150 million by 2028, at a CAGR of 9.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

IgG1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibody Therapeutics and Blood Antibody Therapeutics include Roche, Abbvie, Johnson & Johnson, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antibody Therapeutics and Blood Antibody Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody Therapeutics and Blood Antibody Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antibody Therapeutics and Blood Antibody Therapeutics Market Segment Percentages, by Type, 2021 (%)

IgG1

IgG4

Others

Global Antibody Therapeutics and Blood Antibody Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antibody Therapeutics and Blood Antibody Therapeutics Market Segment Percentages, by Application, 2021 (%)

Autoimmune

Tumor

Others

Global Antibody Therapeutics and Blood Antibody Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antibody Therapeutics and Blood Antibody Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibody Therapeutics and Blood Antibody Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antibody Therapeutics and Blood Antibody Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Abbvie

Johnson & Johnson

Bristol-Myers Squibb

Novartis

Merck

Alexion Pharmaceuticals

Takeda

Amgen

Biogen

UCB

Eli Lilly and Company

AstraZeneca

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Antibody Therapeutics and Blood Antibody Therapeutics Market

Leave This Empty: